by Teri Koehler | Mar 23, 2016 | Spotlight
Transitional cell carcinoma of the bladder, the second most common urologic malignancy, is amenable to early diagnosis. This study presents the potential prognostic benefit for a less invasive modification to the standard endoscopic approach. To evaluate the risk...
by Teri Koehler | Mar 23, 2016 | Spotlight
The diagram lists the classifications of Bladder Cancer and what layers of the bladder the tumor has invaded. Stage 0a, also known as noninvasive papillary carcinoma, abnormal cells that may lead to cancer are present in only the epithelial layer of the bladder...
by Teri Koehler | Mar 21, 2016 | Spotlight
Today I toured The Caring Place and all I can say is what an amazing group of people and what they offer to the local community is wonderful. Here is some information about The Caring Place: The Caring Place, a program of Nevada Childhood Cancer Foundation, is...
by Teri Koehler | Mar 17, 2016 | Spotlight
INTRODUCTION – The treatment of high-risk non-muscle-invasive bladder cancer (NMIBC) utilizes transurethral resection followed by adjuvant intravesical immunotherapy or chemotherapy. Intravesical bacillus Calmette-Guérin (BCG) is the mainstay of adjuvant...
by Teri Koehler | Mar 16, 2016 | Spotlight
Diabetes Mellitus Type 2: A Driving Force for Urological Complications. Type 2 diabetes mellitus (T2DM) is a growing epidemic associated with many adverse complications. Urological complications of diabetes mellitus in men are gaining recognition. Previously unknown...
